222 related articles for article (PubMed ID: 16439872)
1. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
[TBL] [Abstract][Full Text] [Related]
2. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP
Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
[TBL] [Abstract][Full Text] [Related]
4. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
[TBL] [Abstract][Full Text] [Related]
5. [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease].
Yang ZX; Sun H; Shen W
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):823-6. PubMed ID: 19032865
[TBL] [Abstract][Full Text] [Related]
6. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
Andersen O; Eugen-Olsen J; Kofoed K; Iversen J; Haugaard SB
J Med Virol; 2008 Feb; 80(2):209-16. PubMed ID: 18098145
[TBL] [Abstract][Full Text] [Related]
8. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
Ahmed MH; Byrne CD
Drug Discov Today; 2007 Sep; 12(17-18):740-7. PubMed ID: 17826687
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte-derived hormone levels in HIV lipodystrophy.
Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
11. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
[TBL] [Abstract][Full Text] [Related]
13. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
14. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.
Pettinelli P; Videla LA
J Clin Endocrinol Metab; 2011 May; 96(5):1424-30. PubMed ID: 21325464
[TBL] [Abstract][Full Text] [Related]
19. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
20. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
